Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wierer

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature Microbiology|July 31, 2025
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolismYong Fan, Liwei Lyu, Ruben Vazquez-Uribe, et al.
Nature Communications|February 19, 2025
Human skeletal muscle fiber heterogeneity beyond myosin heavy chainsRoger Moreno-Justicia, Thibaux Van der Stede, Ben Stocks, et al.
Nature Metabolism|July 23, 2020
Functional identity of hypothalamic melanocortin neurons depends on Tbx3Carmelo Quarta, Alexandre Fisette, Yanjun Xu, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature Microbiology|July 31, 2025
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolismYong Fan, Liwei Lyu, Ruben Vazquez-Uribe, et al.
Nature Communications|February 19, 2025
Human skeletal muscle fiber heterogeneity beyond myosin heavy chainsRoger Moreno-Justicia, Thibaux Van der Stede, Ben Stocks, et al.
Nature Metabolism|July 23, 2020
Functional identity of hypothalamic melanocortin neurons depends on Tbx3Carmelo Quarta, Alexandre Fisette, Yanjun Xu, et al.
Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Pageof 6